Loading...
Enoxaparin
India Pharmaceutical Trade Intelligence
Who Supplies Enoxaparin to India from FRANCE
India's enoxaparin imports from FRANCE total $2.7B across 70 shipments from 4 foreign suppliers. SANOFI-AVENTIS SINGAPORE PTE LTD leads with $2.7B in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include SANOFI INDIA LIMITED. This corridor reflects India's pharmaceutical import demand for enoxaparin — a diversified sourcing base with multiple active suppliers from FRANCE.
Top foreign suppliers (FRANCE) — Ranked by import value
SANOFI-AVENTIS SINGAPORE PTE LTD is the leading Enoxaparin supplier from FRANCE to India, with import value of $2.7B across 40 shipments. The top 5 suppliers — SANOFI-AVENTIS SINGAPORE PTE LTD, SANOFI-AVENTIS SINGAPORE PTE LIMITED, RX SOURCE LIMITED, EPHARM LIMITED — collectively account for 100.0% of total import value from this origin.
Top foreign suppliers (FRANCE)
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | SANOFI-AVENTIS SINGAPORE PTE LTD | $2.7B | 40 | 99.8% |
| 2 | SANOFI-AVENTIS SINGAPORE PTE LIMITED | $5.6M | 26 | 0.2% |
| 3 | RX SOURCE LIMITED | $9.4K | 3 | 0.0% |
| 4 | EPHARM LIMITED | $4.6K | 1 | 0.0% |
Showing top 4 of 4 foreign suppliers · Indian Customs (DGFT) · TransData Nexus
Top Indian buyers (importing from FRANCE)
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | SANOFI INDIA LIMITED | $2.7B | 66 | 100.0% |
| 2 | BIOLOGICAL E. LIMITED | $9.4K | 3 | 0.0% |
| 3 | ACULIFE HEALTHCARE PRIVATE LIMITED | $4.6K | 1 | 0.0% |
Import Statistics
- Import Value
- $2.7B
- Shipments
- 70
- Foreign Suppliers
- 4
- Indian Buyers
- 3
- Avg. Shipment
- $38.4M
Other Enoxaparin Import Origins
Related Analysis
Frequently Asked Questions — Enoxaparin Imports from FRANCE
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
QWho are the top Enoxaparin suppliers from FRANCE to India?
The top Enoxaparin suppliers from FRANCE to India include SANOFI-AVENTIS SINGAPORE PTE LTD, SANOFI-AVENTIS SINGAPORE PTE LIMITED, RX SOURCE LIMITED. The leading supplier is SANOFI-AVENTIS SINGAPORE PTE LTD with import value of $2.7B USD across 40 shipments. India imported Enoxaparin worth $2.7B USD from FRANCE in total across 70 shipments.
QHow much Enoxaparin does India import from FRANCE?
India imported Enoxaparin worth $2.7B USD from FRANCE across 70 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
QWho are the main Indian buyers of Enoxaparin from FRANCE?
The main Indian buyers of Enoxaparin sourced from FRANCE include SANOFI INDIA LIMITED, BIOLOGICAL E. LIMITED, ACULIFE HEALTHCARE PRIVATE LIMITED. The largest buyer is SANOFI INDIA LIMITED with $2.7B in imports across 66 shipments.
QWhat is the total value of Enoxaparin imports from FRANCE to India?
The total value of Enoxaparin imports from FRANCE to India is $2.7B USD, across 70 shipments and 4 foreign suppliers. Data source: Indian Customs (DGFT).
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
SS
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: FRANCE to India pharmaceutical import trade corridor identified from Indian Customs (DGFT) shipping bill records for Enoxaparin.
- 2.Supplier/Buyer Matching: 4 foreign suppliers from FRANCE and 3 Indian buyers identified using company name normalization across customs records.
- 3.Value Aggregation: Total import value of $2.7B aggregated from 70 verified shipping bill records. All values reported in FOB USD as recorded by Indian Customs.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
70 Verified Shipments
4 suppliers, 3 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists